Home |
Free Dividend Report |
Stock Splits Calendar |
UTHR Stock Split History |
Preferred Stock Newsletter |
UTHR Options Chain |
UTHR Message Board |
United Therapeutics (UTHR) has 1 split in our UTHR split history database. The split for UTHR took place on September 23, 2009. This was a 2 for 1 split, meaning for each share of UTHR owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.
When a company such as United Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the UTHR split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into United Therapeutics shares, starting with a $10,000 purchase of UTHR, presented on a split-history-adjusted basis factoring in the complete UTHR split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/24/2014 | |
End date: | 04/22/2024 | |
Start price/share: | $93.50 | |
End price/share: | $234.06 | |
Dividends collected/share: | $0.00 | |
Total return: | 150.33% | |
Average Annual Total Return: | 9.61% | |
Starting investment: | $10,000.00 | |
Ending investment: | $25,038.65 | |
Years: | 10.00 |
About United Therapeutics |
United Therapeutics is a biotechnology company. Co. markets and sells four commercial therapies in the U.S. to treat pulmonary arterial hypertension: Tyvaso® (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin® (treprostinil) Injection (Remodulin); Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, which is approved for treatment of high-risk neuroblastoma, and the Remunity® Pump for Remodulin. According to our UTHR split history records, United Therapeutics has had 1 split. |
UTHR Split History Table | |
Date | Ratio |
09/23/2009 | 2 for 1 |
Healthcare Stock Splits |
UTHR is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
VAR Split History Also explore: UTHR shares outstanding history
Free UTHR Email Alerts:
|
UTHR Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.